tirzepatide fda news #Zepbound (#tirzepatide aka #mounjaro) just got approved for the management of Obesity. Previously, Mounjaro was only approved for #diabetes. This is great news! #t2d #t2diabetes #tiktokpartner Zepbound (tirzepatide) FDA Approval History

Seu diferencial est na proposta de cuidado regenerativo do couro cabeludo e dos folculos, podendo ser inserido como estratgia complementar em protocolos capilares modernos

It may also interact with anti-arrhythmic drugs, such as propafenone and mexiletine, as well as anticoagulant medications

These problems were found in clinical trials

Tirzepatide associated with greater weight loss in women than men All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this years Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept)